Skip to main content
Log in

Bariatric Surgery Outcomes in Patients with Previous Organ Transplant: Scoping Review and Analysis of the MBSAQIP

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Obesity is a major risk factor for transplant. Laparoscopic bariatric surgery (LBS) offers transplant patient benefits including improved comorbidities, graft function, and longevity. We completed a scoping review and analyzed the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) to determine the risk-benefit profile of LBS after transplant. We also compared laparoscopic sleeve gastrectomy (LSG) to laparoscopic Roux-en-Y gastric bypass (LRYGB) following transplant.

Methods

Univariate analysis determined between group differences with subgroup analysis comparing LSG versus LRYGB in transplant patients. Multivariable analysis assessed whether prior transplant was independently associated with major complications or mortality.

Results

A total of 469 (0.1%) patients had previous transplant and had more comorbidities and more often underwent LSG. Operative time (93.9 min vs 83 min, p < 0.001) and length of stay were longer. Major complications were threefold higher in patients with a transplant history (9.6% vs 3.2%; p < 0.001. Previous transplant was the second greatest independent predictor for major complication (OR 2.14 [1.54–2.98], p = < 0.001) but was not predictive of death (OR 1.06 [0.14–8.13] p = 0.956).

Amongst transplant patients, LRYGB demonstrated higher rates of leak (n = 1), VTE, AKI, unplanned intubation, and readmission.

Conclusions

The 30-day complication rate from LBS is three times higher amongst patients with a transplant. LSG is likely the best surgical approach. Despite risks, post-transplant patients incur important benefits from LBS. Surgeons must be aware of this risk-benefit profile when determining LBS candidacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Patel YA, Berg CL, Moylan CA. Nonalcoholic fatty liver disease: key considerations before and after liver transplantation. Dig Dis Sci. 2016;61(5):1406–16.

    Article  CAS  Google Scholar 

  2. Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015 Jan;25(1):134–42.

    Article  Google Scholar 

  3. Suraweera D, Saab EG, Choi G, et al. Bariatric surgery and liver transplantation. Gastroenterol Hepatol. 2017;13(3):170–5.

    Google Scholar 

  4. Tichansky DS, Madan AK. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg. 2005;15(10):1481–6.

    Article  Google Scholar 

  5. Hadjievangelou N, Kulendran M, McGlone ER, et al. Is bariatric surgery in patients following renal transplantation safe and effective? A best evidence topic. Int J Surg. 2016;28:191–5.

    Article  Google Scholar 

  6. Modanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation. 2009;87(8):1167–73.

    Article  Google Scholar 

  7. Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5.

    Article  Google Scholar 

  8. Tsamalaidze L, Elli EF. Bariatric surgery is gaining ground as treatment of obesity after heart transplantation: report of two cases. Obes Surg. 2017;27(11):3064–7.

    Article  Google Scholar 

  9. Yemini R, Nesher E, Winkler J, et al. Bariatric surgery in solid organ transplant patients: long-term follow-up results of outcome, safety, and effect on immunosuppression. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2018;18(11):2772–80.

    Article  Google Scholar 

  10. Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation. 2001;72(1):156–9.

    Article  CAS  Google Scholar 

  11. Golomb I, Winkler J, Ben-Yakov A, et al. Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant. 2014;14(10):2384–90.

    Article  CAS  Google Scholar 

  12. Alexander JW, Goodman H. Gastric bypass in chronic renal failure and renal transplant. Nutr Clin Pract. 2007;22(1):16–21.

    Article  Google Scholar 

  13. Al-Sabah S, Christou NV. Laparoscopic gastric bypass after cardiac transplantation. Surg Obes Relat Dis. 2008;4(5):668–70.

    Article  Google Scholar 

  14. Velez JP, Arias RH, Olaya P. Laparoscopic sleeve gastrectomy on heart transplant recipient with body mass index of 34 kg/m2 and metabolic syndrome. Surg Obes Relat Dis. 2012;8(1):e6–7.

    Article  Google Scholar 

  15. Salinas A, Mc Quattie Pimentel AC, Salinas HM. Roux-en-Y gastric bypass as metabolic treatment in a heart transplant patient with type 2 diabetes: 4 years later. Surg Obes Relat Dis. 2014;10(6):e81–3.

    Article  Google Scholar 

  16. Khullar V, Dolganiuc A, Firpi RJ. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease. World J Transplant. 2014;4(2):81–92.

    Article  Google Scholar 

  17. Guckelberger O, Mutzke F, Glanemann M, et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transplant. 2006;12(3):394–401.

    Article  Google Scholar 

  18. Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant. 2001;16(8):1545–9.

    Article  CAS  Google Scholar 

  19. Gill JS. Cardiovascular disease in transplant recipients: current and future treatment strategies. Clin J Am Soc Nephrol. 2008;3(Supplement 2):S29.

    Article  Google Scholar 

  20. Berthoux F, Mariat C. Cardiovascular death after renal transplantation remains the first cause despite significant quantitative and qualitative changes. Transplantation. 2010;89(7):806.

    Article  Google Scholar 

  21. Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2010;10(6):1420–7.

    Article  CAS  Google Scholar 

  22. American College of Surgeons. MBSAQIP Participant Use Data File (PUF). American College of Surgeons; 2019 [cited 2019 September 14]; Available from: https://www.facs.org/quality-programs/mbsaqip/participant-use.

  23. Beckmann S, Nikolic N, Denhaerynck K, Binet I, Koller M, Boely E, et al. Evolution of body weight parameters up to 3 years after solid organ transplantation: the prospective Swiss Transplant Cohort Study. Clin Transplant. 2017;31(3).

  24. Andalib A, Aminian A, Khorgami Z, et al. Early postoperative outcomes of primary bariatric surgery in patients on chronic steroid or immunosuppressive therapy. Obes Surg. 2016;26(7):1479–86.

    Article  Google Scholar 

  25. Hefler J, Dang J, Modasi A, Switzer N, Birch DW, Karmali S. Effects of chronic corticosteroid and immunosuppressant use in patients undergoing bariatric surgery. Obes Surg. 2019;1–7.

  26. Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(6):1040–60.

    Article  Google Scholar 

  27. Verdonk RC, Buis CI, Porte RJ, et al. Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transplant. 2006;12(5):726–35.

    Article  Google Scholar 

  28. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013;33(1):14–22.

    Article  CAS  Google Scholar 

  29. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14(6):1480–6.

    Article  Google Scholar 

  30. Ashrafian H, le Roux Carel W, Darzi A, et al. Effects of bariatric surgery on cardiovascular function. Circulation. 2008;118(20):2091–102.

    Article  Google Scholar 

  31. Kindel TL, Strande JL. Bariatric surgery as a treatment for heart failure: review of the literature and potential mechanisms. Surg Obes Relat Dis. 2018;14(1):117–22.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jerry T. Dang.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethics Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. Informed consent does not apply.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 25 kb)

ESM 2

(DOCX 25 kb)

ESM 3

(DOCX 29 kb)

ESM 4

(DOCX 29 kb)

Appendix

Appendix

Data collection definitions

Leak—defined by any of the following: reoperation for anastomotic/staple line leak, readmission for anastomotic/staple line leak, reintervention for anastomotic/staple line leak, drain present 30 days postoperatively, or death caused by anastomotic/staple line leak.

Postoperative VTE—defined by any of the following: reoperation for pulmonary embolism or venous thrombosis, readmission for pulmonary embolism or venous thrombosis, reintervention for pulmonary embolism or venous thrombosis, venous thrombosis requiring anticoagulation therapy, pulmonary embolism requiring anticoagulation therapy, and does not include anticoagulation for presumed/suspected VTE.

Postoperative bleed—defined by any of the following: reoperation for bleed, readmission for bleed, reintervention for bleed, transfusion required in first 72 h of surgery start time, and death caused by bleeding.

Major complication—defined by any of the following: cardiac complications, pneumonia, acute renal failure, reoperation, reintervention, venous thromboembolism, deep surgical site infection, wound disruption, sepsis, unplanned intubation, leak, bleed, coma > 24 h, and cerebral vascular accident.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verhoeff, K., Dang, J.T., Modasi, A. et al. Bariatric Surgery Outcomes in Patients with Previous Organ Transplant: Scoping Review and Analysis of the MBSAQIP. OBES SURG 31, 508–516 (2021). https://doi.org/10.1007/s11695-020-05042-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-020-05042-w

Keywords

Navigation